India's Sun Pharma Q1 profit boosted by Gleevec generic
MUMBAI, Aug 12 (Reuters) - Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: generic, Gleevec, India's, States, the United, leukaemia, version, first, of the, launch, exclusive, helped, estimates, analysts', profit that, quarterly, reported, drugmaker, largest, Industries, Pharmaceutical, (Reuters), MUMBAI, boosted, profit, Pharma
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/du9DIHCYdy0/sun-pharma-results-idUSL3N1AJ2HB